RXQ Compounding Recalls Hydromorphone Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling hydromorphone syringes because the company cannot ensure the product is sterile.
- Product
- HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
- Category
- Drug
- Distribution
- Distributed nationwide